Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesca Battaglin

Showing results (1-10 of 81) with videos related to

Pageof 9
Sort By:
JCO Oncology Practice|November 12, 2024
Clinical Applications of Circulating Tumor DNA Profiling in GI CancersFrancesca Battaglin, Heinz-Josef Lenz
Journal of the National Cancer Institute|January 17, 2019
What Should We Do Better? Lessons from Negative Results of a Biomarker Validation StudyFrancesca Battaglin, Heinz-Josef Lenz
Current Treatment Options in Oncology|November 7, 2018
Management of Advanced Small Bowel CancerAlberto Puccini, Francesca Battaglin, Heinz-Josef Lenz
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 30, 2024
Reply to A. Sartore-Bianchi et alFrancesca Battaglin, Fang-Shu Ou, Federico Innocenti, et al.
Cancer Cell International|July 17, 2018
Molecular biomarkers in gastro-esophageal cancer: recent developments, current trends and future directionsFrancesca Battaglin, Madiha Naseem, Alberto Puccini, et al.
Cancer Management and Research|August 8, 2019
The impact of panitumumab treatment on survival and quality of life in patients with <i>RAS</i> wild-type metastatic colorectal cancerFrancesca Battaglin, Alberto Puccini, Selma Ahcene Djaballah, et al.
Seminars in Oncology|September 29, 2018
Biomarker-driven and molecular targeted therapies for colorectal cancersMarta Schirripa, Stacey A Cohen, Francesca Battaglin, et al.
Clinical Advances in Hematology & Oncology : H&O|December 14, 2018
Microsatellite instability in colorectal cancer: overview of its clinical significance and novel perspectivesFrancesca Battaglin, Madiha Naseem, Heinz-Josef Lenz, et al.
Journal for Immunotherapy of Cancer|May 13, 2020
Overcoming resistance to anti-PD1 and anti-PD-L1 treatment in gastrointestinal malignanciesAlberto Puccini, Francesca Battaglin, Maria Laura Iaia, et al.
Expert Opinion on Biological Therapy|July 29, 2017
Anti-EGFR monoclonal antibody panitumumab for the treatment of patients with metastatic colorectal cancer: an overview of current practice and future perspectivesFrancesca Battaglin, Vincenzo Dadduzio, Francesca Bergamo, et al.
Pageof 9

Showing results (1-10 of 81) with videos related to

Sort By:
Pageof 9
JCO Oncology Practice|November 12, 2024
Clinical Applications of Circulating Tumor DNA Profiling in GI CancersFrancesca Battaglin, Heinz-Josef Lenz
Journal of the National Cancer Institute|January 17, 2019
What Should We Do Better? Lessons from Negative Results of a Biomarker Validation StudyFrancesca Battaglin, Heinz-Josef Lenz
Current Treatment Options in Oncology|November 7, 2018
Management of Advanced Small Bowel CancerAlberto Puccini, Francesca Battaglin, Heinz-Josef Lenz
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 30, 2024
Reply to A. Sartore-Bianchi et alFrancesca Battaglin, Fang-Shu Ou, Federico Innocenti, et al.
Cancer Cell International|July 17, 2018
Molecular biomarkers in gastro-esophageal cancer: recent developments, current trends and future directionsFrancesca Battaglin, Madiha Naseem, Alberto Puccini, et al.
Cancer Management and Research|August 8, 2019
The impact of panitumumab treatment on survival and quality of life in patients with <i>RAS</i> wild-type metastatic colorectal cancerFrancesca Battaglin, Alberto Puccini, Selma Ahcene Djaballah, et al.
Seminars in Oncology|September 29, 2018
Biomarker-driven and molecular targeted therapies for colorectal cancersMarta Schirripa, Stacey A Cohen, Francesca Battaglin, et al.
Clinical Advances in Hematology & Oncology : H&O|December 14, 2018
Microsatellite instability in colorectal cancer: overview of its clinical significance and novel perspectivesFrancesca Battaglin, Madiha Naseem, Heinz-Josef Lenz, et al.
Journal for Immunotherapy of Cancer|May 13, 2020
Overcoming resistance to anti-PD1 and anti-PD-L1 treatment in gastrointestinal malignanciesAlberto Puccini, Francesca Battaglin, Maria Laura Iaia, et al.
Expert Opinion on Biological Therapy|July 29, 2017
Anti-EGFR monoclonal antibody panitumumab for the treatment of patients with metastatic colorectal cancer: an overview of current practice and future perspectivesFrancesca Battaglin, Vincenzo Dadduzio, Francesca Bergamo, et al.
Pageof 9